This NUR 2474 Pharmacology for Professional Nursing Exam 2 2026/2027 resource provides a comprehensive 90-page collection of exam-style questions, correct answers, rationales, medication-safety principles, drug interactions, adverse effects, laboratory monitoring, and patient-teaching scenarios. The document concentrates heavily on cardiovascular pharmacology before progressing into anticoagulation and gastrointestinal pharmacology. Major topics include diuretics, ACE inhibitors, ARBs, calcium-channel blockers, beta blockers, heart-failure medications, digoxin, antiarrhythmics, statins, bile-acid sequestrants, antianginal drugs, anticoagulants, GERD and ulcer medications, laxatives, and antiemetics.
The diuretic and antihypertensive pharmacology questions review furosemide, hydrochlorothiazide, spironolactone, bumetanide, captopril, enalapril, ramipril, eplerenone, verapamil, nifedipine, and amlodipine. Clinical scenarios address pulmonary edema, potassium disturbances, renal considerations, first-dose hypotension, ACE-inhibitor cough, pregnancy precautions, renal artery stenosis, reflex tachycardia, constipation, peripheral edema, and clinically significant medication interactions. The resource repeatedly connects pharmacologic mechanisms to nursing assessments, including blood pressure, heart rate, potassium levels, renal status, fluid overload, and patient safety.
The heart failure and cardiac pharmacology section covers RAAS inhibition, beta blockers, diuretics, aldosterone antagonists, and cardiac glycosides. Digoxin receives detailed attention through therapeutic plasma levels, apical-pulse assessment, potassium status, toxicity recognition, drug interactions, and characteristic findings such as visual disturbances. The material also examines amiodarone therapy, including pulmonary, hepatic, ophthalmic, thyroid, and dermatologic concerns and the baseline assessments associated with its use.
Another major component addresses lipid-lowering and antianginal pharmacology. Students review HMG-CoA reductase inhibitors such as rosuvastatin, simvastatin, and lovastatin, with emphasis on liver-function monitoring, myopathy/rhabdomyolysis, LDL reduction, exercise and dietary measures, and medication administration. Cholestyramine and colesevelam questions emphasize bile-acid sequestration, constipation management, medication timing, interactions, and blood-glucose considerations. Antianginal material examines nitroglycerin, beta blockers, and calcium-channel blockers, including preload and myocardial oxygen demand, sublingual dosing scenarios, transdermal therapy, reflex tachycardia, stable versus worsening anginal symptoms, and patient education.
The anticoagulation section provides applied questions on heparin, warfarin, dabigatran, coagulation monitoring, bleeding complications, and reversal agents. Students encounter clinical scenarios involving postoperative DVT, pulmonary embolism, atrial fibrillation, prolonged aPTT, PT/INR interpretation, heparin-associated hemorrhage, protamine sulfate, vitamin K, and conversion from warfarin to dabigatran. The questions emphasize recognizing situations requiring rapid anticoagulation and distinguishing monitoring and reversal strategies for different anticoagulant therapies.
Later portions expand into gastrointestinal pharmacology, including therapies for peptic ulcer disease and GERD, antacids, H2-receptor antagonists, proton-pump inhibitors, H. pylori treatment, metronidazole precautions, laxatives, bowel-cleansing agents, lactulose, polyethylene glycol, senna, and antiemetics such as ondansetron. Patient-teaching questions address medication timing, alcohol interactions, long-term GERD treatment, constipation management, expected medication effects, and recognition of common adverse reactions.
The uploaded document does not identify a specific university or provide a verifiable textbook, journal, author, or edition citation, so adding one would require information not supported by the source. It identifies the course as NUR 2474 Pharmacology for Professional Nursing Exam 2 and labels the material as a 2026/2027 update. The source also does not explicitly state a reliable total question count; therefore, the 90-page length is used in the title rather than inventing a question total.
Relevant students: This document is relevant to NUR 2474 students, professional nursing students, RN students, ADN and BSN students, nursing pharmacology students, medical-surgical nursing students, and students preparing for Pharmacology Exam 2. It is particularly useful for learners who need scenario-based practice with cardiovascular medications, medication interactions, adverse effects, therapeutic monitoring, anticoagulation, cardiac drugs, lipid-lowering agents, gastrointestinal medications, and nursing patient education.
Keywords: NUR 2474 Exam 2, NUR 2474 pharmacology, NUR 2474 Pharm Exam 2, Pharmacology for Professional Nursing, NUR , pharmacology Exam 2 questions and answers, nursing pharmacology questions, cardiovascular pharmacology nursing, diuretics nursing, furosemide nursing, spironolactone nursing, ACE inhibitors nursing, ARB pharmacology, calcium channel blockers nursing, beta blockers nursing, heart failure medications, digoxin nursing, digoxin toxicity, amiodarone nursing, hypertension pharmacology, statins nursing, cholesterol medications nursing, rosuvastatin nursing, lovastatin nursing, cholestyramine nursing, colesevelam nursing, nitroglycerin nursing, angina pharmacology, anticoagulants nursing, heparin nursing, warfarin nursing, dabigatran nursing, aPTT monitoring, PT INR monitoring, protamine sulfate, vitamin K antidote, DVT pharmacology, pulmonary embolism pharmacology, GERD medications, proton pump inhibitors, H2 receptor antagonists, H pylori treatment, metronidazole nursing, laxatives nursing, ondansetron nursing, professional nursing exam, nursing medication safety
Content preview
NUR 2474 Pharm Exam 2 -
Pharmacology for Professional
Nursing Exam 2 | {LATEST
2026/ 2027 UPDATE}
COMPLETE ACTUAL AND
AUTHENTIC EXAM | BRAND
NEW!
A patient is brought to the emergency department with shortness of
breath, a respiratory rate of 30 breaths per minute, intercostal
retractions, and frothy, pink sputum. The nurse caring for this patient will
expect to administer which drug?
,a.Furosemide (Lasix)
b.Hydrochlorothiazide (HydroDIURIL)
c.Mannitol (Osmitrol)
d.Spironolactone (Aldactone) - ANSWER ✔✔a.Furosemide (Lasix)
Furosemide, a potent diuretic, is used when rapid or massive
mobilization of fluids is needed. This patient shows severe signs of
congestive heart failure with respiratory distress and pulmonary edema
and needs immediate mobilization of fluid. Hydrochlorothiazide and
spironolactone are not indicated for pulmonary edema, because their
diuretic effects are less rapid. Mannitol is indicated for patients with
increased intracranial pressure and must be discontinued immediately if
signs of pulmonary congestion or heart failure occur.
A patient who is taking digoxin is admitted to the hospital for treatment of
congestive heart failure. The prescriber has ordered furosemide (Lasix).
The nurse notes an irregular heart rate of 86 beats per minute, a
respiratory rate of 22 breaths per minute, and a blood pressure of
130/82 mm Hg. The nurse auscultates crackles in both lungs. Which
laboratory value causes the nurse the most concern?
,a.Blood glucose level of 120 mg/dL
b.Oxygen saturation of 90%
c.Potassium level of 3.5 mEq/L
d.Sodium level of 140 mEq/L - ANSWER ✔✔c.Potassium level of 3.5
mEq/L
This patient has an irregular, rapid heartbeat that might be caused by a
dysrhythmia. This patient's serum potassium level is low, which can
trigger fatal dysrhythmias, especially in patients taking digoxin.
Furosemide contributes to loss of potassium through its effects on the
distal nephron. Potassium-sparing diuretics often are used in conjunction
with furosemide to prevent this complication. This patient's serum
glucose and sodium levels are normal and of no concern at this point,
although they can be affected by furosemide. The oxygen saturation is
somewhat low and needs to be monitored, although it may improve with
diuresis.
A patient has 2+ pitting edema of the lower extremities bilaterally.
Auscultation of the lungs reveals crackles bilaterally, and the serum
COPYRIGHT©NINJANERD 2026/2027. YEAR PUBLISHED 2026. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
3
, potassium level is 6 mEq/L. Which diuretic agent ordered by the
prescriber should the nurse question?
a.Bumetanide (Bumex)
b.Furosemide (Lasix)
c.Spironolactone (Aldactone)
d.Hydrochlorothiazide (HydroDIURIL) - ANSWER
✔✔c.Spironolactone (Aldactone)
Spironolactone is a non-potassium-wasting diuretic; therefore, if the
patient has a serum potassium level of 6 mEq/L, indicating
hyperkalemia, an order for this drug should be questioned. Bumetanide,
furosemide, and hydrochlorothiazide are potassium-wasting diuretics
and would be appropriate to administer in a patient with hyperkalemia.
A nurse preparing to administer morning medications notes that a patient
with a history of hypertension has been prescribed the angiotensin-
converting enzyme (ACE) inhibitor captopril (Capoten) concurrently with
spironolactone (Aldactone). Morning laboratory results reveal a serum